Free Trial

Koninklijke Philips (NYSE:PHG) Upgraded by BNP Paribas to Neutral

Koninklijke Philips (NYSE:PHG - Get Free Report) was upgraded by analysts at BNP Paribas from an "underperform" rating to a "neutral" rating in a research note issued on Tuesday, Marketbeat reports.

A number of other brokerages have also recently issued reports on PHG. UBS Group upgraded Koninklijke Philips from a "sell" rating to a "neutral" rating in a report on Tuesday, April 30th. StockNews.com upgraded Koninklijke Philips from a "buy" rating to a "strong-buy" rating in a report on Thursday, February 8th. Finally, JPMorgan Chase & Co. upgraded Koninklijke Philips from an "underweight" rating to a "neutral" rating in a report on Tuesday, April 30th. Three investment analysts have rated the stock with a hold rating, one has issued a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $19.00.

View Our Latest Research Report on PHG

Koninklijke Philips Stock Performance

Koninklijke Philips stock traded down $0.37 during midday trading on Tuesday, reaching $26.51. 1,223,987 shares of the company's stock were exchanged, compared to its average volume of 1,192,649. Koninklijke Philips has a 52 week low of $17.75 and a 52 week high of $29.44. The firm has a market cap of $24.62 billion, a price-to-earnings ratio of -27.61, a P/E/G ratio of 1.39 and a beta of 0.75. The stock's 50-day simple moving average is $21.22 and its 200 day simple moving average is $21.27. The company has a debt-to-equity ratio of 0.58, a quick ratio of 0.78 and a current ratio of 1.20.


Institutional Investors Weigh In On Koninklijke Philips

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Mondrian Investment Partners LTD raised its position in shares of Koninklijke Philips by 45.1% in the first quarter. Mondrian Investment Partners LTD now owns 9,553,058 shares of the technology company's stock valued at $191,061,000 after buying an additional 2,971,008 shares in the last quarter. FMR LLC raised its position in Koninklijke Philips by 1.7% during the third quarter. FMR LLC now owns 9,516,906 shares of the technology company's stock valued at $189,767,000 after purchasing an additional 155,055 shares in the last quarter. Dimensional Fund Advisors LP raised its position in Koninklijke Philips by 11.1% during the fourth quarter. Dimensional Fund Advisors LP now owns 2,975,893 shares of the technology company's stock valued at $69,428,000 after purchasing an additional 296,716 shares in the last quarter. Brandywine Global Investment Management LLC acquired a new position in Koninklijke Philips during the third quarter valued at approximately $36,544,000. Finally, Envestnet Asset Management Inc. raised its position in Koninklijke Philips by 29.4% during the third quarter. Envestnet Asset Management Inc. now owns 1,447,942 shares of the technology company's stock valued at $28,872,000 after purchasing an additional 328,922 shares in the last quarter. 13.67% of the stock is currently owned by institutional investors and hedge funds.

About Koninklijke Philips

(Get Free Report)

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.

Further Reading

Should you invest $1,000 in Koninklijke Philips right now?

Before you consider Koninklijke Philips, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Koninklijke Philips wasn't on the list.

While Koninklijke Philips currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Featured Articles and Offers

Search Headlines: